BindingDB logo
myBDB logout

BDBM272787 6-((R)-1-phenylethyl)-3-((tetrahydrofuran-3-yl)oxy)-5,6-dihydro-1H-pyrazolo[4,3-g]quinazolin-7(8H)-one::US10065967, Example 38::US9745307, Example 38

SMILES: C[C@@H](N1Cc2cc3c(OC4CCOC4)n[nH]c3cc2NC1=O)c1ccccc1

InChI Key: InChIKey=MMTLHMHTOAOLHQ-JBZHPUCOSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 272787   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM272787
PNG
(6-((R)-1-phenylethyl)-3-((tetrahydrofuran-3-yl)oxy...)
Show SMILES C[C@@H](N1Cc2cc3c(OC4CCOC4)n[nH]c3cc2NC1=O)c1ccccc1
Show InChI InChI=1S/C21H22N4O3/c1-13(14-5-3-2-4-6-14)25-11-15-9-17-19(10-18(15)22-21(25)26)23-24-20(17)28-16-7-8-27-12-16/h2-6,9-10,13,16H,7-8,11-12H2,1H3,(H,22,26)(H,23,24)/t13-,16?/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US9745307 (2017)

More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 1


(Homo sapiens (Human))
BDBM272787
PNG
(6-((R)-1-phenylethyl)-3-((tetrahydrofuran-3-yl)oxy...)
Show SMILES C[C@@H](N1Cc2cc3c(OC4CCOC4)n[nH]c3cc2NC1=O)c1ccccc1
Show InChI InChI=1S/C21H22N4O3/c1-13(14-5-3-2-4-6-14)25-11-15-9-17-19(10-18(15)22-21(25)26)23-24-20(17)28-16-7-8-27-12-16/h2-6,9-10,13,16H,7-8,11-12H2,1H3,(H,22,26)(H,23,24)/t13-,16?/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



Merck, Sharp & Dohme Corp.

US Patent


Assay Description
Activated ERK2 activity was determined in an IMAP-FP assay (Molecular Devices). Using this assay format, the potency (IC50) of each compound was dete...


US Patent US10065967 (2018)

More data for this
Ligand-Target Pair